Trial Profile
Randomised, Double-blind, Placebo Controlled Phase II, Dose-ranging Study of the Safety, Tolerability and Immunogenicity of Live Attenuated ChimeriVax-JE Vaccine (Lyophilised).
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Dec 2012
Price :
$35
*
At a glance
- Drugs Japanese encephalitis vaccine (Primary)
- Indications Japanese encephalitis
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Sanofi
- 25 Sep 2009 New trial record